Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.


Strengths

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.42 for the 2022 fiscal year.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● The company has insufficient levels of profitability.

● The company is not the most generous with respect to shareholders' compensation.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.